title: Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy.
abstract: OBJECTIVE
  The purpose of this study was to determine the association of maternal psychotropic medication use during pregnancy with preterm delivery and other adverse perinatal outcomes.
  
  
  METHODS
  A cohort of 2793 pregnant women in Washington State was interviewed, and their medical files were abstracted. Logistic regression models were constructed to assess odds ratios for perinatal outcomes by use of psychotropic medications.
  
  
  RESULTS
  Maternal use of benzodiazepine during pregnancy was associated with an increased risk of preterm delivery (adjusted odds ratio, 6.79; 95% confidence interval, 4.01-11.5) and with increased risks of low birthweight, low Apgar score, neonatal intensive care unit admissions, and respiratory distress syndrome. Selective serotonin receptor inhibitors were associated with preterm deliveries only among women who started treatment after the first trimester.
  
  
  CONCLUSIONS
  Benzodiazepine was associated highly with preterm delivery and other adverse perinatal outcomes. Well-conducted cohort studies are warranted to draw conclusions about risks and benefits of psychotropic medication use during pregnancy.
authors.affiliation: Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington School of Public Health and Community Medicine, Seattle, WA 98101, USA. ronitc@u.washington.edu
authors.forename: Ronit
authors.initials: R
authors.lastname: Calderon-Margalit
authors.forename: Chunfang
authors.initials: C
authors.lastname: Qiu
authors.forename: Asher
authors.initials: A
authors.lastname: Ornoy
authors.forename: David S
authors.initials: DS
authors.lastname: Siscovick
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Williams
mesh_terms: D000328:Adult; D001569:Benzodiazepines / Q000009:adverse effects; D015331:Cohort Studies; D005260:Female; D006801:Humans; D016015:Logistic Models; D016017:Odds Ratio; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced; D011256:Pregnancy Outcome; D047928:Premature Birth / Q000139:chemically induced*; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012307:Risk Factors; D012702:Serotonin Antagonists / Q000009:adverse effects
chemical_list: D011619:Psychotropic Drugs; D012702:Serotonin Antagonists; D001569:Benzodiazepines
references.citation: JAMA. 2005 May 18;293(19):2372-83
references.pmid: 15900008
references.citation: Am J Psychiatry. 2002 Dec;159(12):2055-61
references.pmid: 12450956
references.citation: Am J Epidemiol. 2002 Feb 15;155(4):293-301
references.pmid: 11836191
references.citation: J Clin Psychopharmacol. 2007 Dec;27(6):607-13
references.pmid: 18004128
references.citation: Birth Defects Res A Clin Mol Teratol. 2007 Apr;79(4):301-8
references.pmid: 17216624
references.citation: Br J Clin Pharmacol. 2008 Nov;66(5):695-705
references.pmid: 18754846
references.citation: Lancet. 2008 Jan 19;371(9608):261-9
references.pmid: 18207020
references.citation: Obstet Gynecol. 2008 Apr;111(4):1001-20
references.pmid: 18378767
references.citation: N Engl J Med. 1996 Oct 3;335(14):1010-5
references.pmid: 8793924
references.citation: J Epidemiol Community Health. 2003 Aug;57(8):565-70
references.pmid: 12883057
references.citation: Prim Care Companion J Clin Psychiatry. 2001 Dec;3(6):232-235
references.pmid: 15014590
references.citation: Health Psychol. 2008 Jan;27(1):43-51
references.pmid: 18230013
references.citation: Lancet. 2008 Jan 5;371(9606):75-84
references.pmid: 18177778
references.citation: BJOG. 2007 Sep;114(9):1055-64
references.pmid: 17565615
references.citation: Am J Obstet Gynecol. 2006 Apr;194(4):961-6
references.pmid: 16580283
references.citation: Reprod Toxicol. 1998 Sep-Oct;12(5):511-5
references.pmid: 9763242
references.citation: Eur J Clin Pharmacol. 2006 Oct;62(10):863-70
references.pmid: 16896784
references.citation: Arch Womens Ment Health. 2005 Sep;8(3):181-9
references.pmid: 15959623
references.citation: Br J Psychiatry. 2008 May;192(5):338-43
references.pmid: 18450656
references.citation: Am J Obstet Gynecol. 2008 Feb;198(2):194.e1-5
references.pmid: 17905176
references.citation: Pediatrics. 2007 Jan;119(1):52-9
references.pmid: 17200271
references.citation: Reprod Toxicol. 1994 Nov-Dec;8(6):461-75
references.pmid: 7881198
references.citation: Lancet Neurol. 2005 Aug;4(8):465-75
references.pmid: 16033689
references.citation: Ann Epidemiol. 1997 Nov;7(8):568-74
references.pmid: 9408553
references.citation: Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1203-10
references.pmid: 17894421
references.citation: Arch Pediatr Adolesc Med. 2004 Apr;158(4):312-6
references.pmid: 15066868